Brady, M;
Rodger, A;
Asboe, D;
Cambiano, V;
Clutterbuck, D;
Desai, M;
Field, N;
... Young, I; + view all
(2019)
BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018.
HIV Medicine
, 20
(S2)
S2-S80.
10.1111/hiv.12718.
Preview |
Text
Cambiano_2018-PrEP-Guidelines.pdf - Accepted Version Download (3MB) | Preview |
Abstract
We aim to provide evidence-based guidance on best clinical practice in the provision, monitoring and support of pre-exposure prophylaxis (PrEP) for the prevention of HIV acquisition. The guidelines include: (i) Guidance on risk assessment prior to PrEP; (ii) Baseline assessment; (iii) Dosing schedules; (iv) Monitoring; (v) Supporting adherence; (vi) Buying generic PrEP; and (vii) Cost-effectiveness. The guidelines are aimed at clinical professionals directly involved in, and responsible for, HIV prevention, and at community advocates and organisations responsible for supporting HIV prevention strategies in those at risk of HIV acquisition. A detailed review of the evidence base is included in Section 4. Sections 5 to 7 are intended to offer practical guidance in risk assessment, starting PrEP, ongoing management while on PrEP and stopping PrEP.
Archive Staff Only
 |
View Item |
